Cite
HARVARD Citation
Molto, C. et al. (2020). Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration. Cancer. 126 (19), pp. 4390-4399. [Online].
This is an interim version of our Electronic Legal Deposit Catalogue-eJournals and eBooks while we continue to recover from a cyber-attack.
Molto, C. et al. (2020). Clinical benefit and cost of breakthrough cancer drugs approved by the US Food and Drug Administration. Cancer. 126 (19), pp. 4390-4399. [Online].